Medical Care, Vol. 45, No. 10, Supplement 2: Comparative Effectiveness and Safety: Emerging Methods (Oct., 2007), pp. S143-S148 (6 pages) Background: In observational research, propensity score ...
A panelist discusses how a large propensity score–matched analysis of 1300 patients aged 60-75 found similar all-cause mortality between intensive chemotherapy and azacitidine plus venetoclax, but ...
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study Patients with ...
Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study To date, evidence ...
The long-acting monoclonal antibody nirsevimab (Beyfortus) protects children younger than 2 years from respiratory syncytial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback